| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.14 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |